Journal
Primary research
Stress Factors Increase Osteoporosis: A ComparativeAssessment of Osteocalcin and Cortisol Levels in Menopausal Women
Osteoporosis, a consequence of menopause in the biological cycle of women, emerges with the conclusion of reproductive capabi lities.
Hormonal changes during this phase contribute to the development of the disease. The study evaluated the relationship between stres s,
salivary cortisol levels, and osteocalcin, in postmenopausal women with osteoporosis.
The study involved a total of 30 postmenopausal volunteers diagnosed with osteoporosis. Stress levels were assessed using the NIH
stress score system to evaluate cortisol levels. Saliva and blood samples were analyzed using the LC-MS/MS and ELISA methods.
Samples were collected from the participants during the 1st week and in the 2nd week after they were informed about their diagnosis. Statistical analyses, including the Wilcoxon Signed Rank test, paired samples t-tests, and correlation analyses, were conducted using IBM SPSS Statistics 21.0. A significance level of p<0.05 was considered.
In comparing stress scores between the first/second weeks, a statistically significant difference was observed (z=4.795,p<0.001),
indicating a higher mean stress score in the second week. Cortisol levels showed a significant increase from the 1st week(27.58±3.97) to
the 2nd week (29.99±2.44)(t=4.412,p<0.001). Osteocalcin values exhibited a significant difference between the 1st week(21.04±0.98) and
the 2nd week (24.22±1.44)(t=9.656, p<0.001). Examining participant variations, the mean difference in stress scores was 7.73±2.23, the
mean difference in cortisol levels was 2.41±2.99, and the mean difference in osteocalcin levels was 3.18±1.81. A weak positive
statistically significant relationship was found between stress score difference and cortisol difference (r=0.363, p=0.049). In contrast, an
intermediate-level positive statistically significant relationship was observed between osteocalcin difference and cortisol difference
(r=0.586, p=0.001). Findings demonstrate the intricate relationships between stress, cortisol levels, and osteocalcin.
Contrary to some existing findings, our study suggests that menopause, as a stress -inducing factor, leads to an increase in bone
metabolism markers, including cortisol. Insights contribute to a more comprehensive understanding of the interplay between stress,
hormonal changes, and osteoporosis in postmenopausal women.
MORE FROM RESEARCH
-
Using Copper to Improve the Well-Being of the Skin
Copper has two key properties that are being exploited in consumer and medical device products in the last decade. On the one hand, copper has potent biocidal properties. On the other hand, copper is involved in numerous physiological and metabolic processes critical for the appropriate functioning of almost all tissues in the human body. In…
-
Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions
While osteoporosis and psychological stress occur via differing mechanisms, there are several potential molecular links that exist between a pathological response to stress and the development of bone disease. Although not a comprehensive list, these may include dysregulation of the HPA-axis and SAM pathway, inflammatory pathways, IGF signaling, estrogen, serotonin, GABA, and RANKL. SOURCE
-
Role of cortisol in the pathogenesis of postmenopausal osteoporosis: relationship to bone structure
Excess glucocorticoids are well recognised as a cause of osteoporosis; they inhibit osteoblast function and increase osteoblast and osteocyte apoptosis resulting in thinning of the trabeculae. The circadian rhythm of bone turnover, which is linked to cortisol rhythm, is abnormal in osteoporosis. Furthermore, some studies show abnormal cortisol metabolism in osteoporosis. The aim of our…
-
Stress Factors Increase Osteoporosis: A ComparativeAssessment of Osteocalcin and Cortisol Levels in Menopausal Women
Osteoporosis, a consequence of menopause in the biological cycle of women, emerges with the conclusion of reproductive capabi lities.Hormonal changes during this phase contribute to the development of the disease. The study evaluated the relationship between stres s,salivary cortisol levels, and osteocalcin, in postmenopausal women with osteoporosis. The study involved a total of 30 postmenopausal…
-
Association of Menopausal Vasomotor Symptoms With Increased Bone Turnover During the Menopausal Transition
The purpose of this study was to determine the longitudinal association between menopausal vasomotor symptoms (VMS) and urinary N-telopeptide level (NTX) according to menopausal stage. We conclude that among early perimenopausal and late perimenopausal women, those with VMS had higher bone turnover than those without VMS. Prior to the final menstrual period, VMS may be a…
-
Presence of vasomotor symptoms is associated with lower bone mineral density
Objective: To determine whether women with vasomotor symptoms (VMS) have lower bone mineral density (BMD) than women without VMS. Design We analyzed data from baseline to annual follow-up visit 5 for 2213 participants in the bone substudy of the Study of Women’s Health Across the Nation. At baseline, women were aged 42 to 52 years,…
-
Osteocalcin, a promising marker of osteoporosis: evaluation in post-menopausal females with osteoporosis
Background: Osteocalcin, has high affinity for calcium. In osteoporotic women, deficiency of calcium may lead to lowering of the formation of hydroxyapatite crystals. Thus, in the state of hypo mineralization, free osteocalcin available in the circulation. Therefore, present study was designed to evaluate significance of serum osteocalcin in diagnosis of osteoporosis, and relationship between Serum Osteocalcin…